Twice-yearly injectable lenacapavir treatment shows 100pc efficacy in HIV prevention. » Capital News

KISII, Kenya, Aug 1 – Twice-yearly injectable Lenacapavir treatment for HIV has demonstrated 100 percent efficacy for HIV prevention in cisgender women. At the International AIDS Conference, Linder Gail Bekker a scientist and principal investigator for the South Africa study…